Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TIMOTEO CABRERA

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1144295064
CMS profile
324442
Location
SAN ANTONIO, TX

General Payments · PY2018–2024

$3,465.07

  • Reported across 79 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$870.83

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $870.83 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $249.00 2
Medtronic, Inc. $183.76 5
VentureMed Group, Inc. $178.36 2
Lilly USA, LLC $124.99 1
Aurinia Pharma U.S., Inc. $106.11 1
BARD PERIPHERAL VASCULAR, INC. $14.97 1
BIOTRONIK INC. $13.64 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $72.32 3
PY2019 $423.51 8
PY2020 $121.32 7
PY2021 $727.38 20
PY2022 $715.00 21
PY2023 $534.71 7
PY2024 $870.83 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $124.00 02/27/2024 Food and Beverage Undisputed 01/23/2026 1105726895 CMS
AstraZeneca Pharmaceuticals LP $125.00 04/30/2024 Food and Beverage Undisputed 01/23/2026 1105250728 CMS
Aurinia Pharma U.S., Inc. $106.11 11/07/2024 Food and Beverage Undisputed 01/23/2026 1150677319 CMS
Bard Peripheral Vascular, Inc. $14.97 10/01/2024 Food and Beverage Undisputed 01/23/2026 1128476769 CMS
BIOTRONIK INC. $13.64 05/14/2024 Food and Beverage Undisputed 01/23/2026 1145805139 CMS
Lilly USA, LLC $124.99 04/24/2024 Food and Beverage Undisputed 01/23/2026 1135465204 CMS
Medtronic, Inc. $33.39 08/06/2024 Food and Beverage Undisputed 01/23/2026 1117082219 CMS
Medtronic, Inc. $58.08 08/22/2024 Food and Beverage Undisputed 01/23/2026 1117082221 CMS
Medtronic, Inc. $28.62 09/17/2024 Food and Beverage Undisputed 01/23/2026 1117082223 CMS
Medtronic, Inc. $36.93 10/22/2024 Food and Beverage Undisputed 01/23/2026 1117082225 CMS
Medtronic, Inc. $26.74 10/29/2024 Food and Beverage Undisputed 01/23/2026 1117082227 CMS
VentureMed Group, Inc. $152.87 03/06/2024 Food and Beverage Undisputed 01/23/2026 1123468616 CMS
VentureMed Group, Inc. $25.49 10/10/2024 Food and Beverage Undisputed 01/23/2026 1123469139 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.